OraSure Technologies Total Assets 2010-2025 | OSUR

OraSure Technologies total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
OraSure Technologies Annual Total Assets
(Millions of US $)
2024 $480
2023 $483
2022 $444
2021 $461
2020 $454
2019 $349
2018 $316
2017 $296
2016 $208
2015 $189
2014 $190
2013 $184
2012 $191
2011 $128
2010 $123
2009 $127
OraSure Technologies Quarterly Total Assets
(Millions of US $)
2025-03-31 $458
2024-12-31 $480
2024-09-30 $464
2024-06-30 $466
2024-03-31 $468
2023-12-31 $483
2023-09-30 $458
2023-06-30 $454
2023-03-31 $459
2022-12-31 $444
2022-09-30 $432
2022-06-30 $429
2022-03-31 $436
2021-12-31 $461
2021-09-30 $456
2021-06-30 $465
2021-03-31 $456
2020-12-31 $454
2020-09-30 $436
2020-06-30 $421
2020-03-31 $325
2019-12-31 $349
2019-09-30 $339
2019-06-30 $327
2019-03-31 $319
2018-12-31 $316
2018-09-30 $304
2018-06-30 $292
2018-03-31 $286
2017-12-31 $296
2017-09-30 $282
2017-06-30 $258
2017-03-31 $233
2016-12-31 $208
2016-09-30 $204
2016-06-30 $200
2016-03-31 $188
2015-12-31 $189
2015-09-30 $194
2015-06-30 $180
2015-03-31 $178
2014-12-31 $190
2014-09-30 $191
2014-06-30 $180
2014-03-31 $174
2013-12-31 $184
2013-09-30 $178
2013-06-30 $174
2013-03-31 $182
2012-12-31 $191
2012-09-30 $197
2012-06-30 $125
2012-03-31 $125
2011-12-31 $128
2011-09-30 $123
2011-06-30 $121
2011-03-31 $119
2010-12-31 $123
2010-09-30 $122
2010-06-30 $124
2010-03-31 $121
2009-12-31 $127
2009-09-30 $128
2009-06-30 $122
2009-03-31 $127
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.184B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.007B 27.90
Boston Scientific (BSX) United States $155.135B 38.84
Stryker (SYK) United States $149.698B 31.30
EssilorLuxottica (ESLOY) France $129.877B 0.00
Medtronic (MDT) Ireland $110.440B 16.12
Lonza Group Ag (LZAGY) Switzerland $48.984B 0.00
Haleon (HLN) United Kingdom $48.101B 27.36
ResMed (RMD) United States $36.449B 27.38
GE HealthCare Technologies (GEHC) United States $33.384B 15.85
Agilent Technologies (A) United States $32.046B 21.17
Terumo (TRUMY) Japan $27.153B 35.27
Koninklijke Philips (PHG) Netherlands $22.822B 16.41
Insulet (PODD) United States $22.662B 88.96
Zimmer Biomet Holdings (ZBH) United States $19.138B 12.29
Baxter (BAX) United States $15.929B 11.89
Smith & Nephew SNATS (SNN) United Kingdom $12.591B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.618B 23.03
Lantheus Holdings (LNTH) United States $5.520B 13.92
Prestige Consumer Healthcare (PBH) United States $4.305B 19.23
Perrigo (PRGO) Ireland $3.614B 9.16
Haemonetics (HAE) United States $3.485B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.459B 25.51
Envista Holdings (NVST) United States $3.066B 25.48
QuidelOrtho (QDEL) United States $2.234B 15.36
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.882B 42.07
AtriCure (ATRC) United States $1.599B 0.00
Neogen (NEOG) United States $1.424B 18.22
AdaptHealth (AHCO) United States $1.220B 12.38
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
Green Thumb Industries (GTBIF) United States $1.209B 27.19
BioLife Solutions (BLFS) United States $1.045B 0.00
InMode (INMD) Israel $1.023B 9.37
Phibro Animal Health (PAHC) United States $0.966B 12.35
Evolus (EOLS) United States $0.645B 0.00
CeriBell (CBLL) United States $0.636B 0.00
Curaleaf Holdings (CURLF) Canada $0.586B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.516B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.499B 0.00
Tilray Brands (TLRY) Canada $0.443B 0.00
Capricor Therapeutics (CAPR) United States $0.437B 0.00
Surmodics (SRDX) United States $0.401B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.95
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.279B 49.60
Sanara MedTech (SMTI) United States $0.274B 0.00
Verano Holdings (VRNOF) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Cerus (CERS) United States $0.247B 0.00
Canopy Growth (CGC) Canada $0.246B 0.00
ZimVie (ZIMV) United States $0.242B 11.00
Omeros (OMER) United States $0.230B 0.00
Biote (BTMD) United States $0.220B 6.18
Brainsway (BWAY) Israel $0.188B 49.90
High Tide (HITI) Canada $0.187B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.51
Quanterix (QTRX) United States $0.175B 0.00
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Jin Medical (ZJYL) China $0.129B 0.00
TerrAscend (TSNDF) Canada $0.128B 0.00
Exagen (XGN) United States $0.122B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.084B 10.83
Veru (VERU) United States $0.075B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Quipt Home Medical (QIPT) United States $0.065B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 13.00
Rockwell Medical (RMTI) United States $0.033B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.023B 30.57
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.019B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00